home All News open_in_new Full Article
La Comisión Europea autoriza finalmente el lecanemab, el fármaco que ralentiza el deterioro del alzhéimer
today 3 w. ago attach_file Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
ID: 3909346737